Search

David Pirlot

Examiner (ID: 12288)

Most Active Art Unit
3202
Art Unit(s)
2833, 3202
Total Applications
1812
Issued Applications
1572
Pending Applications
21
Abandoned Applications
219

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19324845 [patent_doc_number] => 12042498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-23 [patent_title] => Compound useful for the treatment of degenerative and inflammatory diseases [patent_app_type] => utility [patent_app_number] => 17/230483 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22607 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230483 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/230483
Compound useful for the treatment of degenerative and inflammatory diseases Apr 13, 2021 Issued
Array ( [id] => 17505080 [patent_doc_number] => 20220098182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => COMPOUNDS ACTIVE TOWARDS NUCLEAR RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/218555 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26587 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17218555 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/218555
Compounds active towards nuclear receptors Mar 30, 2021 Issued
Array ( [id] => 18347435 [patent_doc_number] => 20230135545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => BIOMIMETIC G-QUARTET COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/915713 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915713 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915713
BIOMIMETIC G-QUARTET COMPOUNDS Mar 29, 2021 Pending
Array ( [id] => 17126142 [patent_doc_number] => 20210300910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => PHEBOX LIGANDS AND METHODS OF MAKING SAME [patent_app_type] => utility [patent_app_number] => 17/209850 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209850 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/209850
Phebox ligands and methods of making same Mar 22, 2021 Issued
Array ( [id] => 16977543 [patent_doc_number] => 20210221780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same [patent_app_type] => utility [patent_app_number] => 17/206265 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13168 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206265
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 16977542 [patent_doc_number] => 20210221779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => Acesulfame Potassium Compositions and Processes for Producing Same [patent_app_type] => utility [patent_app_number] => 17/206208 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12261 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206208 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206208
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 18559760 [patent_doc_number] => 11724994 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Acesulfame potassium compositions and processes for producing same [patent_app_type] => utility [patent_app_number] => 17/206230 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15924 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206230 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206230
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 20480314 [patent_doc_number] => 12528785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => MDM2 degraders and uses thereof [patent_app_type] => utility [patent_app_number] => 17/912416 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 159703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912416 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/912416
MDM2 degraders and uses thereof Mar 18, 2021 Issued
Array ( [id] => 18545255 [patent_doc_number] => 11718594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => Acesulfame potassium compositions and processes for producing same [patent_app_type] => utility [patent_app_number] => 17/206191 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16050 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206191 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206191
Acesulfame potassium compositions and processes for producing same Mar 18, 2021 Issued
Array ( [id] => 18753897 [patent_doc_number] => 20230357222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON [patent_app_type] => utility [patent_app_number] => 17/911564 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17911564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/911564
SELECTIVE SMALL MOLECULE DEGRADERS OF CEREBLON Mar 15, 2021 Abandoned
Array ( [id] => 16977587 [patent_doc_number] => 20210221824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/203457 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203457 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/203457
HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE Mar 15, 2021 Abandoned
Array ( [id] => 17065721 [patent_doc_number] => 20210267936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => COMBINATION THERAPIES [patent_app_type] => utility [patent_app_number] => 17/202755 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202755 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202755
Combination therapies Mar 15, 2021 Issued
Array ( [id] => 17185168 [patent_doc_number] => 20210332053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => HETEROCYCLIC COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/201878 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201878
Heterocyclic compound and use thereof Mar 14, 2021 Issued
Array ( [id] => 16946614 [patent_doc_number] => 20210205305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/201750 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 120074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201750 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201750
Spirocyclic compounds as tryptophan hydroxylase inhibitors Mar 14, 2021 Issued
Array ( [id] => 17020858 [patent_doc_number] => 20210244729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION [patent_app_type] => utility [patent_app_number] => 17/201736 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201736
NOVEL CRYSTALLINE FORMS OF SELINEXOR AND PROCESS FOR THEIR PREPARATION Mar 14, 2021 Abandoned
Array ( [id] => 17314814 [patent_doc_number] => 20210403862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/195385 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195385 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/195385
Methods of enhancing cell survival of stem cells Mar 7, 2021 Issued
Array ( [id] => 18413097 [patent_doc_number] => 11667630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Nitrogen-containing 6-membered cyclic compound [patent_app_type] => utility [patent_app_number] => 17/192614 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40330 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/192614
Nitrogen-containing 6-membered cyclic compound Mar 3, 2021 Issued
Array ( [id] => 18405747 [patent_doc_number] => 20230167098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => HETEROCYCLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 17/905538 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905538 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905538
Heterocyclic compound Mar 3, 2021 Issued
Array ( [id] => 19808281 [patent_doc_number] => 12239640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target [patent_app_type] => utility [patent_app_number] => 17/430655 [patent_app_country] => US [patent_app_date] => 2021-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5407 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430655
Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target Feb 19, 2021 Issued
Array ( [id] => 17052140 [patent_doc_number] => 20210261574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => BORON-CONTAINING SMALL MOLECULES [patent_app_type] => utility [patent_app_number] => 17/174586 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95991 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174586 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/174586
BORON-CONTAINING SMALL MOLECULES Feb 11, 2021 Abandoned
Menu